These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 5030802)

  • 1. Treatment of malignant melanoma with camptothecin (NSC-100880).
    Gottlieb JA; Luce JK
    Cancer Chemother Rep; 1972 Feb; 56(1):103-5. PubMed ID: 5030802
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II study of camptothecin (NSC-100880) in the treatment of advanced gastrointestinal cancer.
    Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
    Cancer Chemother Rep; 1972 Feb; 56(1):95-101. PubMed ID: 5030811
    [No Abstract]   [Full Text] [Related]  

  • 3. [Polychemotherapy with 5-(3,3 dimethyl-1-triazeno)imidazole-4-carboxamide (DTIC; NSC-45388), 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC-409962) and vincristine (NSC-67574) in the metastatic phase of melanoma].
    Beretta G; Bajetta E; Bonadonna G; Tancini G; Orefice S; Veronesi U
    Tumori; 1973; 59(3):239-48. PubMed ID: 4729646
    [No Abstract]   [Full Text] [Related]  

  • 4. Preliminary pharmacologic and clinical evaluation of camptothecin sodium (NSC-100880).
    Gottlieb JA; Guarino AM; Call JB; Oliverio VT; Block JB
    Cancer Chemother Rep; 1970 Dec; 54(6):461-70. PubMed ID: 4946015
    [No Abstract]   [Full Text] [Related]  

  • 5. Dose-schedule studies with hydroxyurea (NSC-32065) in malignant melanoma.
    Gottlieb JA; Frei E; Luce JK
    Cancer Chemother Rep; 1971 Jun; 55(3):277-80. PubMed ID: 5115848
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical trials of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) given intravenously in the treatment of malignant melanoma in Uganda.
    Vogel CL; Comis R; Ziegler JL; Kiryabwire JW
    Cancer Chemother Rep; 1971 Apr; 55(2):143-9. PubMed ID: 5118684
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase II study of 6 -methylpregn-4-ene-3,11,20-trione (NSC-17256).
    Ramirez G; Weiss AJ; Rochlin DB; Bisel HF
    Cancer Chemother Rep; 1971 Jun; 55(3):265-8. PubMed ID: 5115847
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical experience with 5-(3,3-bis(2-chloroethyl)-1-triazeno)imidazole-4-carboxamide (NSC-82196) in the treatment of metastatic malignant melanoma.
    Falkson G; Van der Merwe AM; Falkson HC
    Cancer Chemother Rep; 1972 Oct; 56(5):671-7. PubMed ID: 4569061
    [No Abstract]   [Full Text] [Related]  

  • 9. [1st experiences in the treatment of ovarian tumors with Peptichemio].
    Natale N; Mangioni C; Remotti G
    Minerva Med; 1974 May; 65(33):1805-10. PubMed ID: 4367233
    [No Abstract]   [Full Text] [Related]  

  • 10. Preliminary clinical experience with cis-diamminedichloroplatinum (II) (NSC 119875, CACP).
    Rossof AH; Slayton RE; Perlia CP
    Cancer; 1972 Dec; 30(6):1451-6. PubMed ID: 4641756
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of auratin in the complex therapy of melanomas].
    Zolotkov AG; Nivinskaia MM; Parshikova SM; Paches LR
    Antibiotiki; 1970 Dec; 15(12):1111-6. PubMed ID: 4100474
    [No Abstract]   [Full Text] [Related]  

  • 12. Ukrain with chemotherapy in malignant melanoma (case report).
    Stabuc B; Benedicic D
    Drugs Exp Clin Res; 1996; 22(3-5):231-3. PubMed ID: 8899337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicity of camptothecin (NSC-100880).
    Schaeppi U; Fleischman RW; Cooney DA
    Cancer Chemother Rep 3; 1974 Sep; 5(1):25-36. PubMed ID: 4213507
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cytostatic treatment of lymphogranulomatosis. Experiences with ibenzmethyzine, cyclophosphamide and vinblastine sulfate].
    Schubert JC; Martin H
    Munch Med Wochenschr; 1968 Jan; 110(2):97-100. PubMed ID: 5695132
    [No Abstract]   [Full Text] [Related]  

  • 15. 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in patients with gastrointestinal carcinoma.
    Moertel CG; Reitemeier RJ; Hahn RG; Schutt AJ
    Cancer Chemother Rep; 1970 Dec; 54(6):471-3. PubMed ID: 4946016
    [No Abstract]   [Full Text] [Related]  

  • 16. [A clinical study of N-nitrosomethylurea].
    Vermel' EM; Korman NP; Milonov BV; Evseenko LS; Orlova RS
    Vopr Onkol; 1970 May; 16(5):31-7. PubMed ID: 4915916
    [No Abstract]   [Full Text] [Related]  

  • 17. [Dose escalation of domestic nedaplatin used in concurrent chemoradiotherapy for cervical cancer].
    Zhu WG; Yu CH; Li T
    Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):525-6. PubMed ID: 22093631
    [No Abstract]   [Full Text] [Related]  

  • 18. Ukrain monotherapy in malignant melanoma (case report).
    Hamler F; Hiesmayr W; Korsh O; Melnyk A
    Drugs Exp Clin Res; 1996; 22(3-5):235-7. PubMed ID: 8899338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis.
    Cao J; Qi F; Liu T
    Scand J Gastroenterol; 2014 Jun; 49(6):690-704. PubMed ID: 24731211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of malignant tumors other than melanoma.
    Kingra GS; Comis R; Olson KB; Horton J
    Cancer Chemother Rep; 1971 Jun; 55(3):281-3. PubMed ID: 5115849
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.